Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective of the study is to determine whether rivaroxaban in addition to standard care reduces the risk of the composite of cardiovascular (CV) death, myocardial infarction (MI), or stroke in subjects with a recent ACS compared with placebo in addition to standard care.
Inclusion criteria
- Acute coronary syndrome (ACS)